Updates and Advances in Diabetes Self-Management Technology

Activity Preview

Diabetes management is constantly evolving, including new treatment options with innovative mechanisms of action, a shift toward more shared decision making and person-centered care, and increased interest in and availability of diabetes technology. Recent changes in diabetes technology have been so significant that the American Diabetes Association (ADA) Standards of Medical Care in Diabetes–2019 has an entirely new section devoted to diabetes technology.

Learning Objectives

At the completion of this activity, the pharmacist will be able to:

  1. Identify useful diabetes-related mobile applications based on their characteristics and functionalities.
  2. Describe the role that mobile applications can play in helping patients manage their diabetes.
  3. Discuss the criteria that should be used to evaluate a mobile app.
  4. Explain the importance of device accuracy when helping patients select technology for glucose monitoring.
  5. Describe the most useful diabetes self-management devices and support tools currently available to patients with diabetes.
  6. Compare the various insulin pens and injectable devices commercially available.

Activity type: Knowledge-based

Target Audience: Pharmacists 

Learning level: 1

Accreditation Information

The American Pharmacists Association is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education.  This activity is approved for 2.0 contact hours of CPE credit (0.20 CEUs). The ACPE Universal Activity Number for this activity is 0202-0000-19-152-H01-P.

To obtain credit for Updates and Advances in Diabetes Self-Management Technology, complete the assessment with a grade of 70% or better, complete the evaluation, and then claim credit. Participants need to have a valid pharmacist.com username and password to claim credit. After credit has been claimed, please visit CPE monitor for your transcript.

APhA's continuing pharmacy education policy allows two opportunities to successfully complete the continuing pharmacy education assessment. Please note that the questions may not appear in the same order as printed and only two attempts to pass the assessment will be granted.  The current policy of the APhA Education Department is to not release the correct answers to any of our CPE tests. This policy is intended to maintain the integrity of the CPE activity and the assessment.

Initial release date: May 1, 2019
Expiration date: May 1, 2022 - NO CREDIT GRANTED AFTER THIS DATE

Development

Updates and Advances in Diabetes Self-Management Technology is a home-study continuing education activity for pharmacists developed by the American Pharmacists Association.

Advisory Board

Jennifer Trujillo, PharmD, Associate Professor
Department of Clinical Pharmacy, University of Colorado Skaggs School of Pharmacy and Pharmaceutical Sciences, Aurora
Andrew Bzowyckyj, PharmD, BCPS, CDE, Associate Professor
Pacific University Oregon School of Pharmacy, Hillsboro

Disclosures

Jennifer Trujillo, PharmD, declares that she is an advisory board member for Sanofi and BD Pharmaceuticals.

Andrew Bzowyckyj, PharmD, BCPS, CDE, and APhA’s Government Affairs and editorial staff declare no conflicts of interest or financial interests in any product or service mentioned in this activity, including grants, employment, gifts, stock holdings, and honoraria. For complete staff disclosures, please see the Education and Accreditation Information section at www.pharmacist.com/apha-disclosures.

Fee

There is no fee associated with this activity for members of the American Pharmacists Association. There is a $25 fee for nonmembers.

System Requirements

Computer and internet access are required to complete this activity.  Please visit our website and view the Technology System Requirements to have a positive learning experience.